Bestatin: LIBERTY2 extension study started

Eiger began the open-label LIBERTY2 extension study of oral Bestatin for ≥24 weeks in about

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE